Detalles de la búsqueda
1.
Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure.
N Engl J Med
; 380(6): 539-548, 2019 02 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30415601
2.
Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial.
Eur Heart J
; 40(40): 3345-3352, 2019 10 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31093657
3.
Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.
JAMA
; 322(11): 1077-1084, 2019 Sep 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-31475296
4.
Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction.
JAMA
; 322(11): 1085-1095, 2019 Sep 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-31475295
5.
Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial.
Am Heart J
; 198: 145-151, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29653636
6.
Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril/Valsartan Therapy for Heart Failure (PROVE-HF).
Am Heart J
; 199: 130-136, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29754651
7.
Change the management of patients with heart failure: Rationale and design of the CHAMP-HF registry.
Am Heart J
; 189: 177-183, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28625374
8.
Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial.
Circulation
; 139(19): 2285-2288, 2019 05 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30955360
9.
Tacrolimus exposure in the real world: an analysis from the Mycophenolic acid Observational REnal transplant study.
Clin Transplant
; 28(7): 768-75, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24754603
10.
Long-term outcomes in African American kidney transplant recipients under contemporary immunosuppression: a four-yr analysis of the Mycophenolic acid Observational REnal transplant (MORE) study.
Clin Transplant
; 28(2): 184-91, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24372743
11.
Long-term dosing patterns of enteric-coated mycophenolate sodium or mycophenolate mofetil with tacrolimus after renal transplantation.
Clin Transplant
; 28(9): 961-7, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24893821
12.
Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hoc analyses of the EPOC trial.
BMC Neurol
; 14: 220, 2014 Nov 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-25424122
13.
A randomized, double-blind study of 30 versus 20 mg dexmethylphenidate extended-release in children with attention-deficit/hyperactivity disorder: late-day symptom control.
J Clin Psychopharmacol
; 32(5): 637-44, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22926597
14.
Association of mycophenolic acid dose with efficacy and safety events in kidney transplant patients receiving tacrolimus: an analysis of the Mycophenolic acid Observational REnal transplant registry.
Clin Transplant
; 26(6): E602-11, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23121178
15.
Immediate versus delayed switch from levodopa/carbidopa to levodopa/carbidopa/entacapone: effects on motor function and quality of life in patients with Parkinson's disease with end-of-dose wearing off.
Int J Neurosci
; 121(11): 605-13, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21843110
16.
Angiotensin Receptor-Neprilysin Inhibition Based on History of Heart Failure and Use of Renin-Angiotensin System Antagonists.
J Am Coll Cardiol
; 76(9): 1034-1048, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32854838
17.
Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated Heart Failure: Secondary Analysis of the Open-label Extension of the PIONEER-HF Trial.
JAMA Cardiol
; 5(2): 202-207, 2020 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31825471
18.
Activity Sensors to Evaluate the Effect of Sacubitril/Valsartan on Quality-of-Life in Heart Failure: rational and design of the AWAKE-HF study.
ESC Heart Fail
; 6(6): 1313-1321, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31638338
19.
Comparison of Hydralazine/Nitrate and Angiotensin Receptor Neprilysin Inhibitor Use Among Black Versus Nonblack Americans With Heart Failure and Reduced Ejection Fraction (from CHAMP-HF).
Am J Cardiol
; 124(12): 1900-1906, 2019 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31679641
20.
Association Between Sacubitril/Valsartan Initiation and Health Status Outcomes in Heart Failure With Reduced Ejection Fraction.
JACC Heart Fail
; 7(11): 933-941, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31521679